Omniox
Omniox is an IND-stage biotherapeutics company focused on developing innovative H-NOX platform technology into first-in-class and best-in-class OMX oxygen delivery vehicles. These biologics are designed to safely deliver oxygen to hypoxic tissues, addressing significant unmet medical needs and improving patient outcomes.
Industries
Nr. of Employees
small (1-50)
Awards
Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)
OMX - A Novel Oxygen Carrier for Non-compressible Torso Hemorrhage in Austere Environments
Funding (ceiling)
$3,431,597.93
Award Year
2024
Patents
Products
Protein-based oxygen delivery therapeutic candidates
Lead biologic candidates based on engineered heme-binding proteins designed to bind and retain oxygen until reaching hypoxic microenvironments, with tunable oxygen affinity, circulation half-life, and tissue penetration profiles.
Protein-based oxygen delivery therapeutic candidates
Lead biologic candidates based on engineered heme-binding proteins designed to bind and retain oxygen until reaching hypoxic microenvironments, with tunable oxygen affinity, circulation half-life, and tissue penetration profiles.
Expertise Areas
- Therapeutic protein engineering
- Oxygen-delivery therapeutics
- Preclinical and IND-stage development
- Process and analytical development for biologics
Key Technologies
- Heme-binding protein engineering
- Protein engineering for oxygen carriers
- Oxygen-affinity tuning
- Protein structural biology
Key People
Jonathan Winger, PhD
Co-Founder and CEO
Julia Simmons
Senior Director, Controller
Alexandra Loucks
Director, Program Management
Jonathan Winger, PhD
Co-Founder and CEO
Julia Simmons
Senior Director, Controller
Alexandra Loucks
Director, Program Management
Investors
Venture Round - Omniox
Announced on 2023-11-01.
Series D - Omniox
Announced on 2018-03-23.
Venture Round - Omniox
$4,708,814 funded.
Announced on 2016-07-27.
Grant - Omniox
$5,800,000 funded.
Announced on 2014-10-09.
Venture Round - Omniox
$6,603,710 funded.
Announced on 2014-06-23.
Venture Round - Omniox
$3,000,000 funded.
Announced on 2013-06-24.
Venture Round - Omniox
Announced on 2023-11-01.
Series D - Omniox
Announced on 2018-03-23.
Venture Round - Omniox
$4,708,814 funded.
Announced on 2016-07-27.
Grant - Omniox
$5,800,000 funded.
Announced on 2014-10-09.
Venture Round - Omniox
$6,603,710 funded.
Announced on 2014-06-23.
Venture Round - Omniox
$3,000,000 funded.
Announced on 2013-06-24.